Biossance
Biossance was founded in 2016 as a consumer skincare arm of Amyris, a publicly traded biotechnology company that developed sugarcane-derived squalane through synthetic biology. The brand brings genuine biotech credentials to clean beauty — its squalane production technology was originally developed in partnership with the Gates Foundation for pharmaceutical applications. Biossance has been operating for nearly a decade with a growing body of clinical testing on its formulations.
Verified reviewer
Biossance, by the numbers.
Biossance has 9 products in the DermFND database, distributed across moisturizers, eye creams, oils, sunscreen, and serums. Observed ingredient patterns show that squalane, hyaluronic acid, vitamin c, glycerin, peptides, ceramides, shea butter, and zinc oxide are the most common components across the analyzed formulations. The price range for these products is $32 to $74, with an average price of $54. The brand maintains an average DermFND score of 69.8/100. Typical product profiles include formulations such as the Squalane + Omega Repair Cream and the Squalane + Vitamin C Dark Spot Serum.
Read full methodology →